Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK5J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,592.57 to Amerisourcebergen Drug Corp for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) on January 28, 2026, with completion targeted for February 19, 2026. This is a firm fixed-price, non-set-aside contract performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The company has demonstrated significant capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through its competitive contract awards with the Defense Logistics Agency and other federal healthcare systems. This particular delivery order for Vyndamax, a treatment for transthyretin cardiac amyloidosis, reflects the company's continued role in supplying specialized medications to support military and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FJK5J?
SPE2DR26FJK5J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FJK5J worth?
The government has obligated $14,593 on SPE2DR26FJK5J.
Is contract SPE2DR26FJK5J an order under another contract?
Yes. SPE2DR26FJK5J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK5J competed?
The extent of competition for SPE2DR26FJK5J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award